Hypertension in Pregnancy

Papers
(The median citation count of Hypertension in Pregnancy is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Genome-wide association study reveals HSF2, GJA1 and TRIM36 as susceptibility genes for preeclampsia: a community-based population study in Tianjin, China15
Inflammasomes in placental explants of women with preeclampsia cultured with monosodium urate may be modulated by vitamin D13
Risk of gestational hypertension and preeclampsia in pregnant women with new onset blood pressure of 120–129/≤89 mmHg: a meta-analysis of prospective studies10
Statement of Retraction: Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial10
Effects of hypertensive disorders of pregnancy on the complications in very low birth weight neonates9
Blood pressure medication use and postpartum hospital readmission among preeclampsia patients9
A clinical and in-silico study exploring the association of CASP-3, NF-kB, miR-187, and miR-146 in pre-eclampsia9
Administration of corticosteroid therapy for HELLP syndrome in pregnant women: evidences from seven randomized controlled trials9
Intraabdominal pressure as a marker for physiologic and pathologic processes in pregnancy8
Expression of Concern: First versus second trimester mean platelet volume and uric acid for prediction of preeclampsia in women at moderate and low risk7
Targeting oxidative stress in preeclampsia7
Coronavirus disease 2019 (COVID-19) and the risk of hypertensive disorders of pregnancy: a retrospective cohort study7
Short stature in small-for-gestational-age offspring born to mothers with hypertensive disorders of pregnancy6
First-trimester maternal renin-angiotensin-aldosterone system activation and the association with maternal telomere length after natural and IVF/ICSI conceived pregnancies: the Rotterdam periconceptio5
Trimester and severity of SARS-CoV-2 infection during pregnancy and risk of hypertensive disorders in pregnancy5
Association between time of delivery and composite adverse outcomes in pregnancies complicated by hypertensive disorders5
The impact of hyperandrogenemia on pregnancy complications and outcomes in patients with PCOS: a systematic review and meta-analysis5
Predictability of adverse outcomes in hypertensive disorders of pregnancy: a multicenter prospective cohort study5
Association between interleukin-32 gene polymorphism and susceptibility to preeclampsia5
Use of the USCOM® noninvasive cardiac output measurement system to predict the development of pre-eclampsia in hypertensive pregnancies5
IL-25 promotes trophoblast proliferation and invasion via binding with IL-17RB and associated with PE4
Causal associations of metabolic dysfunction-associated steatotic liver disease with gestational hypertension and preeclampsia: a two-sample Mendelian randomization study4
Interleukin-1β and uric acid as potential second-trimester predictive biomarkers of preeclampsia4
Distinguishing preeclampsia using the falling scaled slope (FSS) --- a novel photoplethysmographic morphological parameter4
Magnesium sulfate improves blood flow of uterine, umbilical, and fetal middle cerebral arteries in women with severe preeclampsia at 30-34 gestational weeks3
Maternal and neonatal outcome among women with early-onset preeclampsia and late-onset preeclampsia3
Soluble endoglin versus sFlt-1/PlGF ratio: detection of preeclampsia, HELLP syndrome, and FGR in a high-risk cohort3
Association between hypertensive disorders of pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring: a systematic review and meta-analysis3
Relationship between the hemodynamic profile and resistant hypertension in pregnant patients with hypertensive crisis3
MiR-140-5p exerts a protective function in pregnancy-induced hypertension via mediating TGF-β/Smad signaling pathway3
Would the utilization of sFlt-1/PlGF ratio in clinical practice prevent unnecessary hospital admissions of cases with preeclampsia?3
The obesity associated FTO gene polymorphism and the risk of preeclampsia in Iranian women: A case–control study3
Soluble urinary somatic angiotensin converting enzyme is overexpressed in patients with preeclampsia: a potential new marker for the disease?3
Increased expression of lncRNA SNHG7 promotes the cell viability, migration, and invasion in pre-eclampsia via modulating the miR-214-5p/TWIST1 axis2
Predicting intensive care need in women with preeclampsia using machine learning – a pilot study2
Use of FMF algorithm for prediction of preeclampsia in high risk pregnancies: a single center longitudinal study2
Long-term outcomes of patients with preeclampsia, a review of the literature2
Subclinical myocardial dysfunction in patients with complete recovery from peripartum cardiomyopathy: a long-term clinical strain-echocardiographic study2
Cardiorespiratory fitness in women after severe pre-eclampsia2
Integrated bioinformatics analysis identifies neutrophils and villous cytotrophoblasts infiltration characterized by BLC6 upregulation as associated with the co-occurrence of gestational diabetes mell2
Hypertensive disorders of pregnancy after multifetal pregnancy reduction: a systematic review and meta-analysis2
Down-regulated placental miR-21 contributes to preeclampsia through targeting RASA12
An exploratory study of white blood cell proportions across preeclamptic and normotensive pregnancy by self-identified race in individuals with overweight or obesity1
Total Th1/Th2 cytokines profile from peripheral blood lymphocytes in normal pregnancy and preeclampsia syndrome1
Expression of Concern: Maternal and fetal outcome in women with gestational hypertension in comparison to gestational proteinuria: A 3-year observational study1
Maternal deaths due to hypertensive disorders of pregnancy in Brazil from 2012 until 2023: a cross-sectional populational-based study1
LifeAPP: self-monitoring of blood pressure after preterm preeclampsia: a randomized controlled feasibility trial1
Preeclampsia risk factors in French Guiana: a great heterogeneity among populations and geographic areas1
The association between food groups and preeclampsia: a case-control study1
The effect of preexisting medical comorbidities on the preeclamptic phenotype: a retrospective cohort study1
Cardiovascular and hemodynamic consequences of recombinant placental growth factor administration in Guinea pigs1
Does multiple sclerosis increase the risk of preeclampsia? A systematic review and meta-analysis1
Letter by Lu et al regarding article, “the role of aspirin dose and initiation time in the prevention of preeclampsia and corresponding complications: a meta-analysis of RCTs”1
Assessing the causal association of sleep abnormalities with preeclampsia and eclampsia: a Mendelian randomization analysis1
Letter by Lu et al. regarding article, “Esomeprazole and sulfasalazine in combination additively reduce sFlt-1 secretion and diminish endothelial dysfunction: potential for a combination treatment for1
Predictive value of the sFlt-1/PlGF ratio for preeclampsia in twin pregnancies: a retrospective study1
Associations between extreme temperature exposure and hypertensive disorders in pregnancy: a systematic review and meta-analysis1
Expression of NEDD4L and ENaC in Urinary Extracellular Vesicles in Pre-eclampsia1
Expression of Concern: Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial1
Preconceptual leptin levels in gestational diabetes and hypertensive pregnancy1
Quality improvement: patient education for management of hypertension in pregnancy1
RETRACTED ARTICLE: Protective effect of Fisetin on the lipopolysaccharide-induced preeclampsia-like rats1
0.044489145278931